Active, not recruitingNCT03158922
The BARCODE 1 Pilot Study
Studying Genetic urogenital tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institute of Cancer Research, United Kingdom
- Principal Investigator
- Rosalind A Eeles, FRCP, FRFRInstitute of Cancer Research and Royal Marsden Hospital
- Intervention
- Genetic SNP profiling(genetic)
- Enrollment
- 329 target
- Eligibility
- 55-69 years · MALE
- Timeline
- 2016 – 2028
Study locations (1)
- Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03158922 on ClinicalTrials.govOther trials for Genetic urogenital tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06046131Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.Centre Hospitalier Universitaire de la Guadeloupe
- RECRUITINGPHASE2NCT03833921Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate CancerMartha Mims
- ACTIVE NOT RECRUITINGPHASE1NCT00977457Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing SurgeryCity of Hope Medical Center